Systems and methods for spinal fusion

Information

  • Patent Grant
  • 11638652
  • Patent Number
    11,638,652
  • Date Filed
    Tuesday, October 15, 2019
    4 years ago
  • Date Issued
    Tuesday, May 2, 2023
    a year ago
Abstract
A system and method for spinal fusion comprising a spinal fusion implant of non-bone construction releasably coupled to an insertion instrument dimensioned to introduce the spinal fusion implant into any of a variety of spinal target sites, in particular into the thoracic region of the spine.
Description
BACKGROUND OF THE INVENTION
I. Field of the Invention

The present invention relates generally to spinal surgery and, more particularly, to a system and method for spinal fusion comprising a spinal fusion implant of non-bone construction releasably coupled to an insertion instrument dimensioned to introduce the spinal fusion implant into the thoracic region of the spine.


II. Discussion of the Prior Art

Currently there are nearly 500,000 spine lumbar, thoracic and cervical fusion procedures performed each year in the United States. Such procedures are commonly performed to correct problems, such as chronic back or neck pain, which result from degenerated intervertebral discs or trauma. Generally, spinal fusion procedures involve removing some or the entire diseased or damaged disc, and inserting one or more intervertebral implants into the resulting disc space. Introducing the intervertebral implant serves to restore the height between adjacent vertebrae (“disc height”), which reduces if not eliminates neural impingement commonly associated with a damaged or diseased disc.


Autologous bone grafts are widely used as intervertebral implant for thoracic fusion. Autologous bone grafts are obtained by harvesting a section of bone from the iliac crest of the patient and thereafter implanting the article of autologous bone graft to effect fusion. While generally effective, the use of autologous bone grafts suffers certain drawbacks. A primary drawback is the morbidity associated with harvesting the autologous graft from the patient's iliac crest. Another related drawback is the added surgical time required to perform the bone-harvesting.


Allograft bone grafts have been employed with increased regularity in an effort to overcome the drawbacks of autologous bone grafts. Allograft bone grafts are harvested from cadaveric specimens, machined, and sterilized for implantation. While allograft bone grafts eliminate the morbidity associated with iliac crest bone harvesting, as well as decrease the overall surgical time, they still suffer certain drawbacks. A primary drawback is supply constraint, in that the tissue banks that process and produce allograft bone implants find it difficult to forecast allograft given the inherent challenges in forecasting the receipt of cadavers. Another related drawback is that it is difficult to manufacture the allograft with consistent shape and strength characteristics given the variation from cadaver to cadaver.


The present invention is directed at overcoming, or at least improving upon, the disadvantages of the prior art.


SUMMARY OF THE INVENTION

The present invention overcomes the drawbacks of the prior art by providing a spinal fusion system and related methods involving the use of a spinal fusion implant of non-bone construction. The non-bone construction of the spinal fusion implant of the present invention overcomes the drawbacks of the prior art in that it is not supply limited (as with allograft) and does not require harvesting bone from the patient (as with autograft). The spinal fusion implant of the present invention may be comprised of any suitable non-bone composition, including but not limited to polymer compositions (e.g. poly-ether-ether-ketone (PEEK) and/or poly-ether-ketone-ketone (PEKK)), ceramic, metal or any combination of these materials.


The spinal fusion implant of the present invention may be provided in any number of suitable shapes and sizes depending upon the particular surgical procedure or need. The spinal fusion implant of the present invention may be dimensioned for use in the cervical and/or lumbar spine without departing from the scope of the present invention. For thoracic fusion, the spinal fusion implant of the present invention may be dimensioned, by way of example only, having a width ranging between 15 and 20 mm, a height ranging between 6 and 16 mm, and a length ranging between 20 and 45 mm.


The spinal fusion implant has a top surface, a bottom surface, an anterior side, a posterior side, a proximal side, and a distal side. The spinal fusion implant of the present invention may be provided in such a shape as to promote the proper kyphotic curvature of the spine. Such shape may be accomplished by varying the angle between the top and bottom contact surfaces of the spinal fusion implant to reflect the desired curvature for the vertebral bodies being fused. The desired angle between said top and bottom surfaces may be accomplished by providing the anterior face of the implant with a greater height than the posterior face of the implant. Thus the top and bottom contact surfaces may not be parallel to one another, but rather they may be angled towards one another at the posterior end and angled away from one another at the anterior end.


The spinal fusion implant of the present invention may be provided with any number of additional features for promoting fusion, such as an aperture extending between the upper and lower vertebral bodies which allow a boney bridge to form through the spinal fusion implant of the present invention. Such fusion-promoting aperture may be dimensioned to receive any number of suitable osteoinductive agents, including but not limited to bone morphogenic protein (BMP) and bio-resorbable polymers, including but not limited to any of a variety of poly (D,L-lactide-co-glycolide) based polymers. The spinal fusion implant of the present invention is preferably equipped with one or more lateral openings which aid in visualization at the time of implantation and at subsequent clinical evaluations.


The spinal fusion implant of the present invention may be provided with any number of suitable anti-migration features to prevent the spinal fusion implant from migrating or moving from the disc space after implantation. Suitable anti-migration features may include, but are not necessarily limited to, angled teeth formed along the upper and/or lower surfaces of the spinal fusion implant and/or spike elements disposed partially within and partially outside the top and/or bottom surfaces of the spinal fusion implant. Such anti-migration features provide the additional benefit of increasing the overall surface area between the spinal fusion implant of the present invention and the adjacent vertebrae, which promotes overall bone fusion rates.


The spinal fusion implant of the present invention may be provided with any number of features for enhancing the visualization of the implant during and/or after implantation into a spinal target site. According to one aspect of the present invention, such visualization enhancement features may take the form of the spike elements used for anti-migration, which may be manufactured from any of a variety of suitable materials, including but not limited to a metal, ceramic, and/or polymer material, preferably having radiopaque characteristics. The spike elements may also take any of a variety of suitable shapes, including but not limited to a generally elongated element disposed within the implant such that the ends thereof extend generally perpendicularly from the top and/or bottom surfaces of the implant. The spike elements may each comprise a unitary element extending through upper and lower surfaces or, alternatively, each spike element may comprise a shorter element which only extends through a single surface (that is, does not extend through the entire height of the implant). In any event, when the spike elements are provided having radiodense characteristics and the implant is manufactured from a radiolucent material (such as, by way of example only, PEEK and/or PEKK), the spike elements will be readily observable under X-ray or fluoroscopy such that a surgeon may track the progress of the implant during implantation and/or the placement of the implant after implantation.


The spinal implant of the present invention may be introduced into a spinal target site through the use of any of a variety of suitable instruments having the capability to releasably engage the spinal implant. In a preferred embodiment, the insertion instrument permits quick, direct, accurate placement of the spinal implant of the present invention into the intervertebral space. According to one embodiment, the insertion instrument includes a threaded engagement element dimensioned to threadably engage into a receiving aperture formed in the spinal fusion implant of the present invention.





BRIEF DESCRIPTION OF THE DRAWINGS

Many advantages of the present invention will be apparent to those skilled in the art with a reading of this specification in conjunction with the attached drawings, wherein like reference numerals are applied to like elements and wherein:



FIG. 1 is a perspective view of a spinal fusion system of the present invention, including a thoracic fusion implant releasably coupled to an insertion instrument, according to one embodiment of the present invention;



FIG. 2-4 is a perspective view of the thoracic fusion implant of FIG. 1, illustrating (among other things), a fusion aperture extending between top and bottom surfaces, a plurality of visualization apertures extending through the side walls, and a variety of anti-migration features, according to one embodiment of the present invention;



FIG. 5 is a top view of the thoracic fusion implant of FIG. 1, illustrating (among other things) the fusion aperture and the anti-migration features, according to one embodiment of the present invention;



FIG. 6 is a side view of the thoracic fusion implant of FIG. 1, illustrating (among other things) the visualization aperture, the anti-migration features, and a receiving aperture for releasably engaging the insertion instrument of FIG. 1, according to one embodiment of the present invention;



FIG. 7 is an end view of the thoracic fusion implant of FIG. 1, illustrating (among other things) the receiving aperture formed in the proximal end and the anti-migration features, according to one embodiment of the present invention;



FIG. 8 is an end view of the thoracic fusion implant of FIG. 1, illustrating the distal end and the anti-migration features, according to one embodiment of the present invention;



FIG. 9 is a perspective view of the insertion instrument of FIG. 1 in a fully assembled form, according to one embodiment of the present invention;



FIG. 10 is an enlarged perspective view of the distal region of the insertion instrument of FIG. 1, according to one embodiment of the present invention;



FIG. 11 is a perspective exploded view of the insertion instrument of FIG. 1, illustrating the component parts of the insertion instrument according to one embodiment of the present invention; and



FIG. 12 represents a flourographic image of the implant and is a side view illustrating the “enhanced visualization” feature of the present invention as employed within a thoracic fusion implant according, to one embodiment of the present invention.





DESCRIPTION OF THE PREFERRED EMBODIMENT

Illustrative embodiments of the invention are described below. In the interest of clarity, not all features of an actual implementation are described in this specification. It will of course be appreciated that in the development of any such actual embodiment, numerous implementation-specific decisions must be made to achieve the developers' specific goals, such as compliance with system-related and business-related constraints, which will vary from one implementation to another. Moreover, it will be appreciated that such a development effort might be complex and time-consuming, but would nevertheless be a routine undertaking for those of ordinary skill in the art having the benefit of this disclosure. The fusion implant system disclosed herein boasts a variety of inventive features and components that warrant patent protection, both individually and in combination.



FIG. 1 illustrates, by way of example only, a spinal fusion system 5 for performing spinal fusion between adjacent thoracic vertebrae, including an exemplary spinal fusion implant 10 and an exemplary insertion instrument 20 provided in accordance with the present invention. The spinal fusion implant 10 may be comprised of any suitable non-bone composition having suitable radiolucent characteristics, including but not limited to polymer compositions (e.g. poly-ether-ether-ketone (PEEK) and/or poly-ether-ketone-ketone (PEKK)) or any combination of PEEK and PEKK. The spinal fusion implant 10 of the present invention may be dimensioned, by way of example only, having a width ranging between 15 and 20 mm, a height ranging between 6 and 16 mm, and a length ranging between 20 and 45 mm.


As will be described in detail below, the insertion instrument 20 is configured to releasably maintain the exemplary spinal fusion implant 10 in the proper orientation during insertion into a thoracic disc space and thereafter release to deposit the implant 10. The exemplary spinal fusion implant 10, having been deposited in the disc space, facilitates spinal fusion restoring and maintaining a desired disc height as natural bone growth occurs through and/or past the implant 10, resulting in the formation of a boney bridge extending between the adjacent vertebral bodies. The implant 10 is particularly suited for introduction into the disc space via a lateral (trans-psoas) approach to the spine, but may be introduced in any of a variety of approaches, such as posterior, anterior, antero-lateral, and postero-lateral, without departing from the scope of the present invention (depending upon the sizing of the implant 10).



FIGS. 2-8 depict an example embodiment of the spinal fusion implant 10. The spinal fusion implant 10 has a top surface 31, a bottom surface 33, an anterior side 52, a posterior side 14, a proximal side 22, and a distal side 16. The generally D-shaped circumference of implant 10, shown by way of example only, is configured for placement in the thoracic spine. Preferably the anterior side 52 is dimensioned with a length than that of the posterior side 14. This may be accomplished, by way of example, by providing a large radius of curvature of the corners between the anterior side 52 and the distal and proximal ends 16 and 22, by angling the distal and proximal ends 16 and 22 such that they converge towards each other proximate the anterior side 52, or a combination of both. By way of example only the radius of the corners proximate the anterior side 52 may be approximately 0.25 inch (¼ inch) while the radius of the corners proximate the posterior side 14 may be approximately 0.06 inch ( 1/16 inch). Optionally, to promote the natural kyphotic curvature of the thoracic region of the spine, the posterior side 14 may be dimensioned at a height greater than that of the anterior side 52. This dimensioning allows for the upper 31 and lower surfaces 33 to converge toward one another at the anterior end, thereby forcing the fusing vertebrae to conform to the proper kyphotic curvature. The kyphotic curvature requirements may vary by patient, but the implant angle will likely lie in the range between 1.degree. and 20.degree., with one example embodiment having and angle of 10.degree. In one embodiment, the top and bottom surfaces 31, 33 are generally flat across. However, it can be appreciated by one skilled in the art that the top and bottom surfaces 31, 33 may be provided in any number of suitable shapes, including but not limited to concave and/or convex. When provided as convex shapes, the top and bottom surfaces 31, 33 may better match the natural contours of the vertebral end plates.


The exemplary spinal fusion implant 10 also preferably includes anti-migration features designed to increase the friction between the spinal fusion implant 10 and the adjacent contacting surfaces of the vertebral bodies so as to prohibit migration of the spinal fusion implant 10 after implantation. Such anti-migration features may include ridges 6 provided along the top surface 31 and/or bottom surface 33. Additional anti-migration features may also include a spike element 7 disposed within the proximal region of the implant 10, a spike element 8 disposed within the distal region of the implant 10, and a pair of spike elements 9 disposed within the central region of the implant 10, one on the posterior side 14 and one on the anterior side 52. Thus, in a preferred embodiment, posterior side 14 is imbued with 3 spike elements 7, 8, 9, situated one at each end and the center, while the anterior side 52 is situated with a single spike element, situated near the center. This triangular arrangement of spike elements 7, 8, 9, is adopted for placement in the thoracic spine where the anterior portion of the vertebral body narrows sharply and is in clear proximity to the great vessels. Spike elements 7, 8, 9 may extend from the top surface 31 and/or bottom surface 33 within the respective proximal, distal and central regions of the implant 10. The spike elements 7, 8, 9 may be manufactured from any of a variety of suitable materials, including but not limited to a metal, ceramic, and/or polymer material, preferably having radiopaque characteristics. The spike elements 7, 8, 9 may also take any of a variety of suitable shapes, including but not limited to a generally elongated element disposed within the implant 10 such that the ends thereof extend generally perpendicularly from the upper and/or lower surfaces 31, 33 of the implant 10. As best appreciated in FIGS. 6-8, the spike elements 7, 8, 9 may each comprise a unitary element extending through top and bottom surfaces 31, 33. Alternatively, each spike element 7, 8, 9 may comprise a shorter element which only extends through a single surface 31, 33 (that is, does not extend through the entire height of the implant 10). In any event, when the spike elements 7, 8, 9 are provided having radiodense characteristics and the implant 10 is manufactured from a radiolucent material (such as, by way of example only, PEEK and/or PEKK), the spike elements 7, 8, 9 will be readily observable under X-ray or fluoroscopy such that a surgeon may track the progress of the implant 10 during implantation and/or the placement of the implant 10 after implantation.


The spinal fusion implant 10 of the present invention may be provided with any number of additional features for promoting fusion, such as an aperture 2 extending between the upper and lower vertebral bodies which allow a boney bridge to form through the spinal fusion implant 10. According to a still further aspect of the present invention, this fusion may be facilitated or augmented by introducing or positioning various osteoinductive materials within aperture 2 and/or adjacent to the spinal fusion implant 10. Such osteoinductive materials may be introduced before, during, or after the insertion of the exemplary spinal fusion implant 10, and may include (but are not necessarily limited to) autologous bone harvested from the patient receiving the spinal fusion implant 10, bone allograft, bone xenograft, any number of non-bone implants (e.g. ceramic, metallic, polymer), bone morphogenic protein, and bio-resorbable compositions, including but not limited to any of a variety of poly (D,L-lactide-co-glycolide) based polymers. The large fusion aperture 2 of the implant 10 may be provided in any of a variety of suitable shapes, including but not limited to the generally hourglass shape best viewed in FIG. 5, or a generally, rectangular, circular, oblong and/or triangular shape or any combination thereof. The preferred hourglass shape, shown in FIG. 5, maximizes the open area for boney growth through the implant 10 while still providing added support and contact surface area along the ends and enter of the implant.


The spinal fusion implant 10 of the present invention is preferably equipped with one or more visualization apertures 4 situated along the anterior 14 and posterior 52 sides, which aid in visualization at the time of implantation and at subsequent clinical evaluations. The plurality of visualization apertures 4 will allow a clinician to make visual observations of the degree of bony fusion un-obscured by the anterior 14 or posterior sides 52. Specifically, based on the generally radiolucent nature of the implant 10, the visualization apertures 4 provide the ability to visualize the interior of the implant 10 during X-ray and/or other suitable imaging techniques which are undertaken from the side (or “lateral”) perspective of the implant 10 (e.g. images taken from anterior/posterior position where the implant is inserted in a preferred position from a lateral approach). If fusion has taken place, the visualization apertures 4 will provide a method for the surgeon to make follow up assessments as to the degree of fusion without any visual interference from the spinal fusion implant 10. Further, the visualization apertures 4 will provide an avenue for cellular migration to the exterior of the spinal fusion implant 10. Thus, the spinal fusion implant 10 will serve as additional scaffolding for bone fusion on the exterior of the spinal fusion implant 10. The visualization apertures 4 may be provided in any of a variety of suitable shapes, including but not limited to the generally oblong shape best viewed in FIG. 6, or a generally circular, rectangular and/or triangular shape or any combination thereof.


The spinal fusion implant 10 may be provided with any number of suitable features for engaging the insertion instrument 20 without departing from the scope of the present invention. As best viewed in FIG. 7, one engagement mechanism involves providing a threaded receiving aperture 12 in the proximal sidewall 22 of the spinal fusion implant 10 of the present invention. The threaded receiving aperture 12 is dimensioned to threadably receive a threaded connector 24 on the insertion instrument 20 (as will be described in greater detail below). The receiving aperture 12 extends inwardly from the proximal side 22 in a generally perpendicular fashion relative to the proximal side 22. Although shown as having a generally circular cross-section, it will be appreciated that the receiving aperture 12 may be provided having any number of suitable shapes or cross-sections, including but not limited to rectangular or triangular. In addition to the receiving aperture 12, the spinal fusion implant 10 is preferably equipped with a pair of grooved purchase regions 60, 61 extending generally horizontally from either side of the receiving aperture 12. The grooved purchase regions 60, 61 are dimensioned to receive corresponding distal head ridges 62, 63 on the insertion instrument 20 (as will be described in greater detail below), which collectively provide an enhanced engagement between the implant 10 and the insertion instrument 20.



FIGS. 9-11 detail the exemplary insertion instrument 20 according to one embodiment of the invention. The exemplary insertion instrument 20 includes an elongated tubular element 28 and an inserter shaft 44. The elongated tubular element 28 is constructed with a distal head 26 at its distal end, distal head ridges 62, 63 on the distal end of the distal head 26, a thumbwheel housing 38 at its proximal end and a handle 42 at its proximal end. The elongated tubular element 28 is generally cylindrical and of a length sufficient to allow the device to span from the surgical target site to a location sufficiently outside the patient's body so the handle 42 and the thumbwheel housing 38 can be easily accessed by a clinician or a complimentary controlling device.


The elongated tubular element 28 is dimensioned to receive a spring 46 and the proximal end of the inserter shaft 44 into the inner bore 64 of the elongated tubular element 28. The inserter shaft 44 is dimensioned such that the threaded connector 24 at the distal end of the inserter shaft 44 just protrudes past the distal head ridges 62, 63 to allow engagement with the receiving aperture 12 of the spinal fusion implant 10. It should be appreciated by one skilled in the art that such a construction allows the inserter shaft 44 to be able to rotate freely within the elongated tubular element 28 while stabilized by the spring 46 to reduce any slidable play in the insertion instrument 20.


The handle 42 is generally disposed at the proximal end of the insertion instrument 20. The handle 42 is fixed to the thumbwheel housing 38 allowing easy handling by the clinician. Because the handle 42 is fixed the clinician has easy access to the thumbwheel 34 and can stably turn the thumbwheel 34 relative to the thumbwheel housing 38. Additionally, the relative orientation of the thumbwheel housing 38 to the handle 42 orients the clinician with respect to the distal head 26 and distal head ridge 62. By way of example, the thumbwheel housing 38 holds a thumbwheel 34, a set screw 32, and a spacer 36. The inserter shaft 44 is attached to the thumbwheel 34 and is freely rotatable with low friction due to the spacer 36. One skilled in the art can appreciate myriad methods of assembling a housing similar to the above described.


The distal head ridges 62, 63 are dimensioned to fit slidably into the purchase regions 60, 61 with low friction to allow accurate engagement of the threaded connector 24 to the receiving aperture 12 of the spinal fusion implant 10. In the presented embodiment, the outer dimension of the threaded connector 24 is smaller than the largest outer dimension of the distal head 26 and elongated tubular element 28. Alternatively, other methods of creating a gripping surface are contemplated including but not limited to knurling or facets.


In order to use the system to perform a spinal fusion procedure, the clinician must first designate the appropriate implant size (and optionally, angulation). After the spinal fusion implant 10 is chosen, the distal head ridges 62, 63 of the inserter shaft 44 are inserted into the purchase regions 60, 61 of the spinal fusion implant 10. At that time the spinal fusion implant 10 and insertion instrument 20 are slidably engaged with one another. Before the clinician can manipulate the combined spinal fusion implant 10 and insertion instrument 20, they must be releasably secured together. In order to secure the spinal fusion implant 10 onto the threaded connector 24 of the inserter instrument 20, the clinician employs the thumbwheel 34 to rotate the inserter shaft 44 and threaded connector 24. The rotation of the threaded connector 24 will releasably engage the receiving aperture 12 of the spinal fusion implant 10 and stabilize the insertion instrument 20 relative to the spinal fusion implant 10.


A clinician can utilize the secured system in either an open or minimally invasive spinal fusion procedure. In either type of procedure, a working channel is created in a patient that reaches the targeted spinal level. After the creation of that channel, the intervertebral space may be prepared via any number of well known preparation tools, including but not limited to kerrisons, rongeurs, pituitaries, and rasps. After preparation, the insertion instrument 20 is used to place a spinal fusion implant 10 into the prepared intervertebral space. Once the implant 10 is inserted into the prepared space, the implant 10 is released from the insertion instrument 20 by rotating the thumbwheel 34 to disengage the threaded connector 24 from the receiving aperture 12. This motion removes the compressive force on the purchase regions 60, 61 between the distal head 26 and the distal head ridges 62, 63 of the spinal fusion implant 10 and allows the insertion instrument to be slidably removed from the implant 10. After the threaded connector 24 is disengaged from the implant 10, the insertion instrument 20 is removed from the working channel and the channel is closed. As previously mentioned, additional materials may be included in the procedure before, during or after the insertion of the spinal fusion implant 10 to aid the natural fusion of the targeted spinal level.


The enhanced visualization features of the implant 10 is explained in greater detail with reference to FIG. 12, illustrating the implant 10 dimensioned particularly for use in a lateral approach having (by way of example only) a width ranging between 15 and 20 mm, a height ranging between 6 and 16 mm, and a length ranging between 20 and 45 mm. Furthermore, FIG. 12 illustrates the implant 10 from a side perspective clearly showing the location of the spike elements 7, 8, 9 relative to the implant 10 and the visualization apertures 4.


While the invention is susceptible to various modifications and alternative forms, specific embodiments thereof have been shown by way of example in the drawings and are herein described in detail. It should be understood, however, that the description herein of specific embodiments is not intended to limit the invention to the particular forms disclosed, but on the contrary, the invention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the invention as defined by the appended claims.


For example, while described herein primarily with reference to the thoracic spinal surgery, it is to be readily appreciated that the spinal fusion implants of the present invention may be suitable for accomplishing fusion in the cervical or lumbar spine without departing from the scope of the present invention. It should be noted that implants designed for the cervical and lumbar regions may be composed in a similar manner, but having a lordosis-promoting shape, rather than the kyphosis promoting shape described above. Specifically, the anterior side may be dimensioned to have a height greater than the posterior side. Those implants 10 designed to be inserted into the cervical region may be very similar to those to be inserted into the thoracic region, albeit smaller, while those designed for the lumbar region may be larger. Moreover, it is to be readily appreciated that the insertion tools described herein may be employed with implants of any number of suitable constructions, including but not limited to metal, ceramic, plastic or composite.


While the invention is susceptible to various modifications and alternative forms, specific embodiments thereof have been shown by way of example in the drawings and are herein described in detail. It should be understood, however, that the description herein of specific embodiments is not intended to limit the invention to the particular forms disclosed, but on the contrary, the invention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the invention as defined herein.

Claims
  • 1. A spinal fusion implant configured to be positioned in an interbody space between a first vertebra and a second vertebra, comprising: a proximal wall;a distal wall;an anterior wall;a posterior wall;an implant upper surface comprising upper surfaces of each of the proximal wall, the distal wall, the anterior wall and the posterior wall;an implant lower surface comprising lower surfaces of each of the proximal wall, distal wall, anterior wall and posterior wall;a plurality of upper ridges on an upper surface of the anterior wall and an upper surface of the posterior wall, each ridge running in a direction perpendicular to the anterior and posterior walls; anda plurality of lower ridges on a lower surface of the anterior wall and a lower surface of the posterior wall, each ridge running in a direction perpendicular to the anterior and posterior walls, anda plurality of anti-migration features, each anti-migration feature including: a portion disposed within one wall selected from the proximal wall, the distal wall, the anterior wall, and the posterior wall,a first end protruding from the implant upper surface, anda second end protruding from the implant lower surface,wherein the plurality of upper ridges and the plurality of lower ridges are configured to resist proximal movement when engaged in the interbody space,wherein the anterior wall has a first length and is configured to face an anatomically anterior aspect of the interbody space while the implant is positioned in the interbody space;wherein the posterior wall has a second length and is configured to face an anatomically posterior aspect of the interbody space while the implant is positioned in the interbody space;wherein the anterior wall meets the distal wall at a first corner having a first corner radius of curvature and meets the proximal wall at a second corner having a second corner radius of curvature;wherein the posterior wall meets the distal wall at a third corner having a third corner radius of curvature and meets the proximal wall at a fourth corner having a fourth corner radius of curvature;wherein the first corner radius of curvature and the second corner radius of curvature are greater than the third corner radius of curvature and the fourth corner radius of curvature such that the second length is greater than the first length; andwherein the plurality of anti-migration features includes: a first spike element including a portion disposed within the proximal wall, the first spike element in proximity to the fourth corner,a second spike element including a portion disposed within the distal wall, the second spike element positioned opposite the first spike element and in proximity to the third corner,a third spike element including a portion disposed within the posterior wall, the third spike element positioned between the first spike element and the second spike element, anda fourth spike element including a portion disposed within the anterior wall, the fourth spike element positioned opposite and parallel to the third spike element.
  • 2. The spinal fusion implant of claim 1, further including a fusion aperture extending through an entire height of the implant extending from the implant upper surface to the implant lower surface to permit bone growth therethrough when the implant is positioned in the interbody space.
  • 3. The spinal fusion implant of claim 2, further including: a first visualization aperture in the anterior wall and in communication with the fusion aperture; anda second visualization aperture in the posterior wall and in communication with the fusion aperture.
  • 4. The spinal fusion implant of claim 3, wherein the anterior wall includes four visualization apertures and the posterior wall includes four visualization apertures, wherein all of the visualization apertures are in communication with the fusion aperture.
  • 5. The spinal fusion implant of claim 4, wherein the four visualization apertures on the anterior wall and the four visualization apertures on the posterior wall each have an oblong shape.
  • 6. The spinal fusion implant of claim 2, wherein the fusion aperture comprises an hourglass shape.
  • 7. The spinal fusion implant of claim 1, further comprising a first radiopaque marker situated in the anterior wall along a medial plane of the implant and a second radiopaque marker situated in the posterior wall along the medial plane of the implant.
  • 8. The spinal fusion implant of claim 1, wherein the proximal wall comprises a threaded tool engagement aperture configured to receive a corresponding portion of an insertion tool for delivering the implant to a target position in the interbody space.
  • 9. The spinal fusion implant of claim 8, wherein the proximal wall further comprises a pair of lateral grooves configured to receive another corresponding portion of the insertion tool, the pair of lateral grooves extending horizontally in opposing directions from the threaded tool engagement aperture.
  • 10. The spinal fusion implant of claim 1, wherein each anti-migration feature in the plurality of anti-migration features comprises a radiopaque material.
  • 11. The spinal fusion implant of claim 1, wherein a portion of the upper surface and a portion of the lower surface of the distal wall are angled relative to one another to provide a tapered distal portion.
  • 12. The spinal fusion implant of claim 1, wherein the first corner radius of curvature and the second corner radius of curvature are the same.
  • 13. The spinal fusion implant of claim 12, wherein the first corner radius of curvature and the second corner radius of curvature are four times greater than the third corner radius of curvature and the fourth corner radius of curvature.
  • 14. The spinal fusion implant of claim 13, wherein the first corner radius of curvature and the second corner radius of curvature are approximately ¼ inch and the third corner radius of curvature and the fourth corner radius of curvature are approximately 1/16 inch.
  • 15. The spinal fusion implant of claim 1, wherein the posterior wall has a height that is greater than the anterior wall.
  • 16. The spinal fusion implant of claim 1, wherein each upper ridge of the plurality of upper ridges extends continuously across a width of the upper surface of the anterior wall and continuously across a width of the upper surface of the posterior wall, respectively, and each lower ridge of the plurality of lower ridges extends continuously across a width of the lower surface of the anterior wall and continuously across a width of the lower surface of the posterior wall, respectively.
  • 17. A spinal fusion implant configured to be positioned in an interbody space between a first vertebra and a second vertebra, comprising: a proximal wall;a distal wall;an anterior wall configured to face an anatomically anterior aspect of the interbody space while the implant is positioned in the interbody space, wherein the anterior wall meets the distal wall at a first corner having a first corner radius of curvature and meets the proximal wall at a second corner having a second corner radius of curvature;a posterior wall configured to face an anatomically posterior aspect of the interbody space while the implant is positioned in the interbody space, wherein the posterior wall meets the distal wall at a third corner having a third corner radius of curvature and meets the proximal wall at a fourth corner having a fourth corner radius of curvature;an implant upper surface comprising upper surfaces of the proximal wall, the distal wall, the anterior wall and the posterior wall;an implant lower surface comprising lower surfaces of the proximal wall, distal wall, anterior wall and posterior wall; anda plurality of anti-migration features, each anti-migration feature including: a portion disposed within one wall selected from the proximal wall, the distal wall, the anterior wall, and the posterior wall,a first end protruding from the implant upper surface, anda second end protruding from the implant lower surface,wherein the plurality of anti-migration features includes: a first spike element including a portion disposed within the proximal wall, the first spike element in proximity to the fourth corner,a second spike element including a portion disposed within the distal wall, the second spike element positioned opposite the first spike element and in proximity to the third corner,a third spike element including a portion disposed within the posterior wall, the third spike element positioned between the first spike element and the second spike element, anda fourth spike element including a portion disposed within the anterior wall, the fourth spike element positioned opposite and parallel to the third spike element.
  • 18. The spinal fusion implant of claim 17, further comprising: a plurality of upper ridges on at least a portion of the implant upper surface; anda plurality of lower ridges on at least a portion of the implant lower surface,wherein the plurality of upper ridges and the plurality of lower ridges are configured to resist proximal movement when engaged in the interbody space.
  • 19. The spinal fusion implant of claim 17, further comprising: a fusion aperture extending through a height of the implant from the implant upper surface to the implant lower surface, wherein the fusion aperture is configured to permit bone growth therethrough when the implant is positioned in the interbody space; andat least one visualization aperture disposed within one wall selected from the anterior wall and the posterior wall, wherein the at least one visualization aperture is in communication with the fusion aperture.
  • 20. The spinal fusion implant of claim 17, further comprising at least one radiopaque marker disposed within one wall selected from the anterior wall and the posterior wall.
CROSS-REFERENCE TO RELATED APPLICATION

This application is a continuation of U.S. patent application Ser. No. 15/893,394, filed Feb. 9, 2018, which is a continuation of U.S. patent application Ser. No. 15/291,494, filed Oct. 12, 2016, which is a continuation of U.S. patent application Ser. No. 14/931,351, filed Nov. 3, 2015 (now U.S. Pat. No. 9,486,329), which is a continuation of U.S. patent application Ser. No. 14/193,866, filed Feb. 28, 2014 (now U.S. Pat. No. 9,186,261), which is a continuation of U.S. patent application Ser. No. 12/044,917, filed Mar. 7, 2008 (now U.S. Pat. No. 8,673,005), which claims the benefit of priority from U.S. Provisional Patent Application Ser. No. 60/905,674, filed Mar. 7, 2007, the entire contents of which are all hereby expressly incorporated by reference into this disclosure as if set forth in its entirety herein.

US Referenced Citations (308)
Number Name Date Kind
472634 Burton Apr 1892 A
473650 Williams Apr 1892 A
503801 Mills Aug 1893 A
530423 Kay Dec 1894 A
3486505 Morrison Dec 1969 A
3518993 Blake Jul 1970 A
3604487 Gilbert Sep 1971 A
3745995 Kraus Jul 1973 A
3848601 Ma et al. Nov 1974 A
3867728 Stubstad et al. Feb 1975 A
4026304 Levy May 1977 A
4026305 Brownlee et al. May 1977 A
4349921 Kuntz Sep 1982 A
4454374 Pollack Jun 1984 A
4501269 Bagby Feb 1985 A
4545374 Jacobson Oct 1985 A
4646738 Trott Mar 1987 A
4657550 Daher Apr 1987 A
4743256 Brantigan May 1988 A
4781591 Allen Nov 1988 A
4834757 Brantigan May 1989 A
4877020 Vich Oct 1989 A
4878915 Brantigan Nov 1989 A
4932975 Main et al. Jun 1990 A
4950296 McIntyre Aug 1990 A
4961740 Ray et al. Oct 1990 A
4962766 Herzon Oct 1990 A
5015247 Michelson May 1991 A
5026373 Ray et al. Jun 1991 A
5047055 Bao et al. Sep 1991 A
5055104 Ray Oct 1991 A
5062845 Kuslich et al. Nov 1991 A
5071437 Steffee Dec 1991 A
5092572 Litwak et al. Mar 1992 A
5133717 Chopin Jul 1992 A
5133755 Brekke Jul 1992 A
5171278 Pisharodi Dec 1992 A
5192327 Brantigan Mar 1993 A
5217497 Mehdian Jun 1993 A
5263953 Bagby Nov 1993 A
5269785 Bonutti Dec 1993 A
5284153 Raymond et al. Feb 1994 A
5290494 Coombes et al. Mar 1994 A
5300076 Leriche Apr 1994 A
5304210 Crook Apr 1994 A
5306307 Senter et al. Apr 1994 A
5306309 Wagner et al. Apr 1994 A
5322505 Krause et al. Jun 1994 A
5334205 Cain Aug 1994 A
5336223 Rogers Aug 1994 A
5364400 Rego, Jr. et al. Nov 1994 A
5395372 Holt et al. Mar 1995 A
5397363 Gelbard Mar 1995 A
5397364 Kozak et al. Mar 1995 A
5405391 Hednerson et al. Apr 1995 A
5413602 Metz-Stavenhagen May 1995 A
5425772 Brantigan Jun 1995 A
5431658 Moskovich Jul 1995 A
5443514 Steffee Aug 1995 A
5443515 Cohen et al. Aug 1995 A
5445639 Kuslich et al. Aug 1995 A
5454811 Huebner Oct 1995 A
5458638 Kuslich et al. Oct 1995 A
5484403 Yoakum et al. Jan 1996 A
5484437 Michelson Jan 1996 A
5489307 Kuslich et al. Feb 1996 A
5489308 Kuslich et al. Feb 1996 A
5514180 Heggeness et al. May 1996 A
5522879 Scopelianos Jun 1996 A
5522899 Michelson Jun 1996 A
5524624 Tepper et al. Jun 1996 A
5527312 Ray Jun 1996 A
5534030 Navarro et al. Jul 1996 A
5540688 Navas Jul 1996 A
5545222 Bonutti Aug 1996 A
5545688 Huang Aug 1996 A
5562736 Ray et al. Oct 1996 A
5565005 Erickson et al. Oct 1996 A
5571190 Ulrich et al. Nov 1996 A
5571192 Schonhoffer Nov 1996 A
5593409 Michelson Jan 1997 A
5607424 Tropiano Mar 1997 A
5609636 Kohrs et al. Mar 1997 A
5611800 Davis et al. Mar 1997 A
5611810 Arnold et al. Mar 1997 A
5632747 Scarborough et al. May 1997 A
5645596 Kim et al. Jul 1997 A
5645598 Brosnahan, III Jul 1997 A
5653761 Pisharodi Aug 1997 A
5653762 Pisharodi Aug 1997 A
5658336 Pisharodi Aug 1997 A
5658337 Kohrs et al. Aug 1997 A
5662710 Bonutti Sep 1997 A
5665122 Kambin Sep 1997 A
5669909 Zdeblick et al. Sep 1997 A
5676703 Gelbard Oct 1997 A
5683394 Rinner Nov 1997 A
5683400 McGuire Nov 1997 A
5683464 Wagner et al. Nov 1997 A
5690629 Asher et al. Nov 1997 A
5700264 Zucherman et al. Dec 1997 A
5700291 Kuslich et al. Dec 1997 A
5700292 Margulies Dec 1997 A
5702449 McKay Dec 1997 A
5702451 Biedermann et al. Dec 1997 A
5702453 Rabbe et al. Dec 1997 A
5702454 Baumgartner Dec 1997 A
5702455 Saggar Dec 1997 A
5703451 Yamamichi Dec 1997 A
5707373 Sevrain et al. Jan 1998 A
5711957 Patat et al. Jan 1998 A
5716415 Steffee Feb 1998 A
5720748 Kuslich et al. Feb 1998 A
5720751 Jackson Feb 1998 A
5728159 Stroever et al. Mar 1998 A
5741253 Michelson Apr 1998 A
5741261 Moskovitz et al. Apr 1998 A
5755797 Baumgartner May 1998 A
5766252 Henry et al. Jun 1998 A
5772661 Michelson Jun 1998 A
5775331 Raymond et al. Jul 1998 A
5775797 Henstra Jul 1998 A
5779642 Nightengale Jul 1998 A
5782830 Farris Jul 1998 A
5782919 Zdeblick et al. Jul 1998 A
5785710 Michelson Jul 1998 A
5797909 Michelson Aug 1998 A
5800549 Bao et al. Sep 1998 A
5800550 Sertich Sep 1998 A
5814084 Grivas et al. Sep 1998 A
5814550 Wolcott Sep 1998 A
5851084 Nishikawa Dec 1998 A
5851208 Trott Dec 1998 A
5860973 Michelson Jan 1999 A
5865845 Thalgott Feb 1999 A
5865848 Baker Feb 1999 A
5885299 Winslow et al. Mar 1999 A
5888219 Bonutti Mar 1999 A
5888224 Beckers et al. Mar 1999 A
5893890 Pisharodi Apr 1999 A
5904719 Errico et al. May 1999 A
5910315 Stevenson et al. Jun 1999 A
5942698 Stevens Aug 1999 A
5954769 Rosenlicht Sep 1999 A
5968098 Winslow Oct 1999 A
5989289 Coates Nov 1999 A
5993474 Ouchi Nov 1999 A
6003426 Kobayashi et al. Dec 1999 A
6004326 Castro et al. Dec 1999 A
6008433 Stone Dec 1999 A
6015436 Schönhoffer Jan 2000 A
6033405 Winslow et al. Mar 2000 A
6033438 Bianchi et al. Mar 2000 A
6039761 Li et al. Mar 2000 A
6042582 Ray Mar 2000 A
6045580 Scarborough et al. Apr 2000 A
6045582 Prybyla Apr 2000 A
6048342 Zucherman et al. Apr 2000 A
6059829 Schlapfer et al. May 2000 A
6063088 Winslow May 2000 A
6080155 Michelson Jun 2000 A
6083225 Winslow et al. Jul 2000 A
6096080 Nicholson et al. Aug 2000 A
6102948 Brosnahan, III Aug 2000 A
6120503 Michelson Sep 2000 A
6120506 Kohrs et al. Sep 2000 A
6132472 Bonutti Oct 2000 A
6143033 Paul et al. Nov 2000 A
6159211 Boriani et al. Dec 2000 A
6159215 Urbahns et al. Dec 2000 A
6193756 Studer et al. Feb 2001 B1
6200347 Anderson et al. Mar 2001 B1
6224607 Michelson May 2001 B1
6224631 Kohrs May 2001 B1
6241769 Nicholson et al. Jun 2001 B1
6241770 Michelson Jun 2001 B1
6241771 Gresser et al. Jun 2001 B1
6245108 Biscup Jun 2001 B1
6251140 Marino et al. Jun 2001 B1
6258125 Paul et al. Jul 2001 B1
6277149 Boyle et al. Aug 2001 B1
6304487 Pawletko et al. Oct 2001 B1
6319257 Carignan et al. Nov 2001 B1
6342074 Simpson Jan 2002 B1
6350283 Michelson Feb 2002 B1
6371988 Pafford Apr 2002 B1
6371989 Chauvin et al. Apr 2002 B1
6383221 Scarborough et al. May 2002 B1
6409766 Brett Jun 2002 B1
6423095 Van Hoeck Jul 2002 B1
6425772 Bernier et al. Jul 2002 B1
6426772 Yoneyama et al. Jul 2002 B1
6432140 Lin Aug 2002 B1
6440142 Ralph et al. Aug 2002 B1
6442814 Landry et al. Sep 2002 B1
6447547 Michelson Sep 2002 B1
6454805 Baccelli et al. Sep 2002 B1
6454806 Cohen et al. Sep 2002 B1
6468311 Boyd et al. Oct 2002 B2
6491724 Ferree Dec 2002 B1
6527773 Lin et al. Mar 2003 B1
6547823 Scarborough et al. Apr 2003 B2
6562072 Fuss et al. May 2003 B1
6595998 Johnson et al. Jul 2003 B2
6599294 Fuss et al. Jul 2003 B2
6626905 Schmiel et al. Sep 2003 B1
6635086 Lin Oct 2003 B2
6648895 Burkus et al. Nov 2003 B2
6672019 Wenz Jan 2004 B1
6676703 Biscup Jan 2004 B2
6706067 Shimp et al. Mar 2004 B2
6712852 Chung Mar 2004 B1
6723097 Fraser et al. Apr 2004 B2
6743255 Ferree Jun 2004 B2
6746484 Liu et al. Jun 2004 B1
6755841 Fraser et al. Jun 2004 B2
6761739 Shepard Jul 2004 B2
6824564 Crozet Nov 2004 B2
6830570 Frey et al. Dec 2004 B1
6923814 Hildebrand et al. Aug 2005 B1
6942698 Jackson Sep 2005 B1
6964687 Bernard et al. Nov 2005 B1
6974480 Messerli et al. Dec 2005 B2
6979353 Bresina Dec 2005 B2
6984245 McGahan et al. Jan 2006 B2
6986788 Paul et al. Jan 2006 B2
6989031 Michelson Jan 2006 B2
7018416 Hanson et al. Mar 2006 B2
7048765 Grooms May 2006 B1
7125425 Foley et al. Oct 2006 B2
7192447 Rhoda Mar 2007 B2
7229477 Biscup Jun 2007 B2
7244258 Burkus et al. Jul 2007 B2
7303583 Schär et al. Dec 2007 B1
7311734 Van Hoeck Dec 2007 B2
7326251 McCombe et al. Feb 2008 B2
7867277 Tohmeh Jan 2011 B1
7951203 McCombe et al. May 2011 B2
8021430 Michelson Sep 2011 B2
8187334 Curran et al. May 2012 B2
8246686 Curran et al. Aug 2012 B1
8251997 Michelson Aug 2012 B2
8361156 Curran et al. Jan 2013 B2
8425612 Perez-Cruet et al. Apr 2013 B2
8506630 Wardlaw Aug 2013 B2
8506636 Dye Aug 2013 B2
8574301 Curran et al. Nov 2013 B2
8579909 Burkus et al. Nov 2013 B2
8591589 McCombe et al. Nov 2013 B2
8608804 Curran et al. Dec 2013 B2
9186261 Pimenta et al. Nov 2015 B2
9918852 Pimenta Mar 2018 B2
20010016741 Burkus et al. Aug 2001 A1
20020019637 Frey et al. Feb 2002 A1
20020058950 Winterbottom et al. May 2002 A1
20020068936 Burkus Jun 2002 A1
20020116008 Lin et al. Aug 2002 A1
20020120334 Crozet Aug 2002 A1
20020138143 Grooms Sep 2002 A1
20020165550 Frey et al. Nov 2002 A1
20030023306 Liu et al. Jan 2003 A1
20030028249 Baccelli et al. Feb 2003 A1
20030100950 Moret May 2003 A1
20030105528 Shimp et al. Jun 2003 A1
20030109928 Pasquet et al. Jun 2003 A1
20030139812 Garcia et al. Jul 2003 A1
20030139813 Messerli Jul 2003 A1
20030149438 Nichols et al. Aug 2003 A1
20040024408 Burkus et al. Feb 2004 A1
20040122518 Rhoda Jun 2004 A1
20040127990 Bartish, Jr. Jul 2004 A1
20040153155 Chung et al. Aug 2004 A1
20040176775 Burkus et al. Sep 2004 A1
20040199251 McCombe et al. Oct 2004 A1
20050049590 Alleyne Mar 2005 A1
20050059971 Michelson Mar 2005 A1
20050113916 Branch May 2005 A1
20050187625 Wolek et al. Aug 2005 A1
20050197702 Coppes Sep 2005 A1
20050203538 Lo et al. Sep 2005 A1
20060074488 Abdou Apr 2006 A1
20060100705 Puno May 2006 A1
20060136061 Navarro Jun 2006 A1
20060142864 Cauthen Jun 2006 A1
20060241760 Randall Oct 2006 A1
20070179612 Johnson et al. Aug 2007 A1
20070191945 Yu et al. Aug 2007 A1
20070276499 Paul et al. Nov 2007 A1
20070282441 Stream Dec 2007 A1
20070288007 Burkus et al. Dec 2007 A1
20080015701 Garcia et al. Jan 2008 A1
20080051890 Waugh Feb 2008 A1
20080058838 Steinberg Mar 2008 A1
20080065219 Dye Mar 2008 A1
20080071372 Butler Mar 2008 A1
20080119937 McCombe et al. May 2008 A1
20090222099 Liu et al. Sep 2009 A1
20100106250 Abdou Apr 2010 A1
20110112642 Tohmeh May 2011 A1
20110196496 McCombe et al. Aug 2011 A1
20120078374 Villiers et al. Mar 2012 A1
20120179261 Soo Jul 2012 A1
20120209388 Curran et al. Aug 2012 A1
20120215317 Curran et al. Aug 2012 A1
20130006363 Ullrich, Jr. et al. Jan 2013 A1
20130138216 Curran et al. May 2013 A1
20130144390 Curran et al. Jun 2013 A1
20130245771 Michelson Sep 2013 A1
Foreign Referenced Citations (38)
Number Date Country
2015507 Jan 1999 CA
0369603 May 1990 EP
0706876 Apr 1995 EP
0667127 Aug 1995 EP
0716840 Jun 1996 EP
0517030 Sep 1996 EP
0737448 Oct 1996 EP
0796593 Sep 1997 EP
0809974 Apr 1998 EP
0809975 Apr 1998 EP
0811356 Apr 1998 EP
0880938 Dec 1998 EP
1990000037 Jan 1990 WO
1991006261 May 1991 WO
1992014423 Sep 1992 WO
1993001771 Feb 1993 WO
1994004100 Mar 1994 WO
1994010928 May 1994 WO
1995001810 Jan 1995 WO
1995008306 Mar 1995 WO
1996008205 Mar 1996 WO
1996017564 Jun 1996 WO
1996041582 Dec 1996 WO
1997020513 Jun 1997 WO
1997033525 Sep 1997 WO
1997037620 Oct 1997 WO
1998009586 Mar 1998 WO
1998014142 Apr 1998 WO
1998017208 Apr 1998 WO
1998025539 Jun 1998 WO
1999008627 Feb 1999 WO
1999038461 Aug 1999 WO
2000044288 Aug 2000 WO
2000045712 Aug 2000 WO
2000045713 Aug 2000 WO
2001041681 Jun 2001 WO
2001049333 Jul 2001 WO
2005058141 Jun 2005 WO
Non-Patent Literature Citations (50)
Entry
Alleyne et al., “Current and future approaches to lumbar disc surgery: A literature review”, MedGenMed, 1999, 1, No. 1.
Appeal from the United States Patent and Trademark Office, Patent Trial and Appeal Board in No. IPR2013-00506, dated Dec. 7, 2016, 13 pgs.
Appeals from the United States Patent and Trademark Office, Patent Trial and Appeal Board in Nos. IPR2013-00507, IPR2013-00508, dated Nov. 9, 2016, 16 pgs.
Baulot et al., “Complementary anterior spondylodesis by thoracoscopy. Technical note regarding an observation”, Lyon Surg., 1994, pp. 347-351, 90, No. 5.
Benini et al., “Undercutting decompression and posterior fusion with translaminar facet screw fixation in degenerative lumbar spinal stenosis: Technique and results”, Neuro-Orthopedics, 1995, pp. 159-172, 17/18.
Berry et al., “A morphometric study of human lumbar and selected thoracic vertebrae”, SPINE, 1987, pp. 362-367, 12, No. 4.
CoRoent® XL & XLR Marketing Brochure (9004225 B.0), NuVasive, Inc., 2006, 2 pgs.
CoRoent® XL & XLR Marketing Brochure (9004225 C.0), NuVasive, Inc., 2007, 2 pgs.
CoRoent® XL Marketing Brochure (9500039 A.0), NuVasive, Inc., 2006, 8 pgs.
CoRoent™ Marketing Brochure (9004001 A.0), NuVasive, Inc., 2004, 2 pgs.
CoRoent™ Marketing Brochure (9004001 C.0), NuVasive, Inc., 2005, 2 pgs.
CoRoent™ XL & XLR Marketing Brochure (9004225 A.0), NuVasive, Inc., 2005, 2 pgs.
Counterclaim Defendants' Corrected Amended invalidity Contentions re U.S. Pat. Nos. 8,000,782; 8,005,535; 8,016,767; 8,192,356; 8,187,334; 8,361,156, D652,922; D666,294 re Case No. 3:12-cv-02738-CAB(MDD), dated Aug. 19, 2013, 30 pgs.
Crock, “A short practice of spinal surgery”, 1993, Springer-Verlag/Wein, New York, 251 pgs.
Crock, “Anterior lumbar interbody fusion”, Clinical Orthopaedics and Related Research, 1982, pp. 157-163, 165.
Decision denying Institution of Inter Partes Review in IPR2013-00504, dated Feb. 13, 2014, 9 pgs.
Decision denying Institution of Inter Partes Review in IPR2013-00506, dated Feb. 13, 2014, 21 pgs.
Decision denying Institution of Inter Partes Review in IPR2013-00507, dated Feb. 13, 2014, 15 pgs.
Decision denying Institution of Inter Partes Review in IPR2013-00508, dated Feb. 13, 2014, 14 pgs.
Declaration of Dr. Hansen A. Yuan from IPR2013-00506, dated May 21, 2014, 63 pgs.
Declaration of Dr. Hansen A. Yuan from IPR2013-00507, dated May 21, 2014, 85 pgs.
Declaration of Dr. Hansen A. Yuan from IPR2013-00508, dated May 21, 2014, 85 pgs.
Declaration of Mary Phelps regarding Telamon Verte-Stack PEEK Vertebral Body Spacer, dated Aug. 13, 2013, 9 pgs.
Declaration of Richard A. Hynes, M.D. regarding U.S. Pat. No. 8,187,334, dated Aug. 14, 2013, 74 pgs.
Declaration of Richard A. Hynes, M.D. regarding U.S. Pat. No. 8,361,156, dated Aug. 14, 2013, 74 pgs.
Declaration of Steven D. DeRidder regarding U.S. Patent Application Publication No. 2002/0165550, dated Jul. 30, 2013, 5 pgs.
Edeland, “Some additional suggestions for an intervertebral disc prosthesis”, Journal of Biomedical Engineering, 1985, pp. 57-62, 7.
Final Written Decision in Medtronic, Inc. v. NuVasive, Inc., Case IPR2013-00507, dated Feb. 11, 2015, 14 pgs.
Final Written Decision in Medtronic, Inc. v. NuVasive, Inc., Case IPR2013-00508, dated Feb. 11, 2015, 19 pgs.
In re NuVasive, Inc., No. 2015-1670,F.3d, 2016 WL 7118526 (Fed. Cir. Dec. 7, 2016), 13 pages.
In re NuVasIve, Inc., Nos. 2015-1672, 2015-1673, 841 F.3d 966 (Fed. Cir. 2016), 16 pages.
Kambin et al., “History and current status of percutaneous arthroscopic disc surgery”, SPINE, 1996, pp. 57S-61S, 21, No. 24S.
Kemp et al., “Anterior fusion of the spine for infective lesions in adults”, The Journal of Bone and Joint Surgery, 1973, pp. 715-734, 55 B, No. 4.
Medtronic Sofamor Danek Boomerang brochure, Medtronic Sofamor Danek, 2003, 6 pages.
Medtronic Sofamor Danek USA, Inc. “Boomerang I Verte-Stack PEEK Vertebral Body Brochure,” 2003, 6 pages.
Medtronic Sofamor Danek USA, Inc. “Boomerang I Verte-Stack PEEK Vertebral Body Spacer Implant,” Apr. 26, 2001, 8 pages.
Medtronic Sofamor Danek USA, Inc. “Boomerang II Verte-Stack PEEK Vertebral Body Spacer Brochure,” 2004, 4 pages.
Medtronic Sofamor Danek USA, Inc. “Boomerang II Verte-Stack PEEK Vertebral Body Spacer Implant,” Dec. 17, 2003, 9 pages.
Medtronic Sofamor Danek USA, Inc. “Boomerang Prototype Verte-Stack PEEK Vertebral Body Spacer Implant,” May 7, 2000, 8 pages.
Medtronic Sofamor Danek USA, Inc. “PCR PEEK Cement Restrictor Brochure,” 2001, 2 pages.
Medtronic Sofamor Danek USA, Inc. “PCR PEEK Cement Restrictor Implant,” Oct. 2, 2001, 17 pages.
Medtronic Sofamor Danek USA, Inc. “Telamon Verte-Stack PEEK Vertebral Body Spacer Brochure I,” 2003, 2 pages.
Medtronic Sofamor Danek USA, Inc. “Telamon Verte-Stack PEEK Vertebral Body Spacer Brochure II,” 2003, 10 pages.
Medtronic Sofamor Danek USA, Inc. “Telamon Verte-Stack PEEK Vertebral Body Spacer Implant,” Oct. 2, 2001, 6 pages.
NuVasive Inc's Patent Owner Response in IPR2013-00506, dated May 21, 2014, 66 pgs.
NuVasive Inc's Patent Owner Response in IPR2013-00507, dated May 21, 2014, 50 pgs.
NuVasive Inc's Patent Owner Response in IPR2013-00508, dated May 21, 2014, 66 pgs.
Nuvasive, Inc., Corrected Final Invalidity Contentions Regarding U.S. Pat. No. 5,860,973, U.S. Pat. No. 6,592,586 and U.S. Pat. No. 6,945,933 filed in the United States District Court, Southern District of California on Jun. 14, 2010 (and 23 appendices).
Patent Owner NuVasive Inc.'s Preliminary Response in IPR2013-00504, dated Nov. 25, 2013, 40 pgs.
Patent Owner NuVasive Inc.'s Preliminary Response in IPR2013-00506, dated Nov. 25, 2013, 38 pgs.
Related Publications (1)
Number Date Country
20200060841 A1 Feb 2020 US
Provisional Applications (1)
Number Date Country
60905674 Mar 2007 US
Continuations (5)
Number Date Country
Parent 15893394 Feb 2018 US
Child 16601833 US
Parent 15291494 Oct 2016 US
Child 15893394 US
Parent 14931351 Nov 2015 US
Child 15291494 US
Parent 14193886 Feb 2014 US
Child 14931351 US
Parent 12044917 Mar 2008 US
Child 14193886 US